https://doi.org/10.1186/s13046-019-1358-x
M
Maoxiao Feng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
1.0K
Citations
15
h-index
18
i10-index
Maoxiao Feng is an academic researcher from Shandong Provincial Hospital. The author has contributed to research in topics: Inflammasome and immune disorders & Heme Oxygenase-1 and Carbon Monoxide & Endoplasmic Reticulum Stress and Disease. The author has an h-index of 15, co-authored 69 publications.
ORCID: 0000-0002-3612-9792Papers by this author
worksDTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation
2019 · Journal of Experimental & Clinical Cancer Research · 140 citations
Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway
2022 · Cell Death and Differentiation · 65 citations
https://doi.org/10.1038/s41418-022-01063-3
m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop
2023 · Oncogene · 50 citations
https://doi.org/10.1038/s41388-023-02704-8
Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine
2014 · BMC Systems Biology · 46 citations
https://doi.org/10.1186/1752-0509-8-82
The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment
2024 · Cell Death and Disease · 11 citations
https://doi.org/10.1038/s41419-024-07145-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat